Advances in gut microbiota functions in inflammatory bowel disease: Dysbiosis, management, cytotoxicity assessment, and therapeutic perspectives
Computational and Structural Biotechnology Journal · 01.01.2025 · 27 · 851-868
DOI: 10.1016/j.csbj.2025.02.026 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Computational and Structural Biotechnology Journal, online erschienen am 03.03.2025. Verfasst von Ivan Kushkevych und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental Biology, Faculty of Science, Masaryk University, Kamenice 5, Brno 625 00, Czech Republic. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 189 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Szegedi Tudományegyetem, Masarykova Univerzita.
Abstract (Originalsprache)
Inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, have become increasingly prevalent across all human generations. Despite advances in diagnosis, effective long-term therapeutic options remain limited, with many patients experiencing recurrent symptoms after treatment. The multifactorial origins of ulcerative colitis are widely recognized, but the intestinal microbiome, particularly bacteria from the Desulfovibrionaceae family, is thought to play a central role in the pathogenesis of the disease. These bacteria contribute significantly to gut microbial functions, yet their cytotoxic and viability characteristics under disease conditions remain poorly understood. Our review provides insights on recent advancements in methodologies for assessing the cytotoxicity and viability of anaerobic intestinal bacteria, with a specific focus on their relevance to gut health and disease. We introduce overview from current literature on modern techniques including flow cytometry, high-throughput screening, and molecular-based assays, highlighting their applications in understanding the role of Desulfovibrionaceae and other gut microbes in IBD pathogenesis. By bridging methodological advancements with functional implications, this review aims to enhance our understanding of gut microbiota-host interactions, which are crucial for maintaining health and preventing disease through immune modulation, where microbiota help regulate immune responses and prevent excessive inflammation; nutrient metabolism, including the breakdown of dietary fibers into short-chain fatty acids that support gut health; and colonization resistance, where beneficial microbes outcompete harmful pathogens to maintain microbial balance.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Experimental Biology, Faculty of Science, Masaryk University, Kamenice 5, Brno 625 00, Czech Republic.
- Department of Plant Origin Food Sciences, Faculty of Veterinary Hygiene and Ecology, University of Veterinary Sciences Brno, Palackého tř. 1946/1, Brno 612 42, Czech Republic.
- Department of Microbiology, Faculty of Biological Sciences, University of Wroclaw, ul. S. Przybyszewskiego 63, Wrocław 51-148, Poland.
- Department of Oral Biology and Experimental Dental Research, Faculty of Dentistry, University of Szeged, Tisza Lajos krt. 62-64, Szeged 6720, Hungary.
- Department of Microbiology and Immunology, Faculty of Pharmacy, Tanta University, Tanta 31527, Egypt.
- Department of Pharmacognosy, Faculty of Pharmacy, Delta University for Science and Technology, International Coastal Road, Gamasa 11152, Egypt.
Förderung
- Szegedi Tudományegyetem
- Masarykova Univerzita
Zitieren
APA
Kushkevych, I., Dvořáková, M., Dordevic, D., Futoma-Kołoch, B., Gajdács, M., Al-Madboly, L. A., & Abd El-Salam, M. (2025). Advances in gut microbiota functions in inflammatory bowel disease: Dysbiosis, management, cytotoxicity assessment, and therapeutic perspectives. Computational and Structural Biotechnology Journal, 27, 851-868. https://doi.org/10.1016/j.csbj.2025.02.026
Vancouver
Kushkevych I, Dvořáková M, Dordevic D, Futoma-Kołoch B, Gajdács M, Al-Madboly LA, et al. Advances in gut microbiota functions in inflammatory bowel disease: Dysbiosis, management, cytotoxicity assessment, and therapeutic perspectives. Computational and Structural Biotechnology Journal. 2025;27:851-868. doi:10.1016/j.csbj.2025.02.026
BibTeX
@article{Kushkevych2025,
author = {Kushkevych, Ivan and Dvořáková, Michaela and Dordevic, Dani and Futoma-Kołoch, Bożena and Gajdács, Márió and Al-Madboly, Lamiaa A and Abd El-Salam, Mohamed},
title = {Advances in gut microbiota functions in inflammatory bowel disease: Dysbiosis, management, cytotoxicity assessment, and therapeutic perspectives},
journal = {Computational and Structural Biotechnology Journal},
year = {2025},
volume = {27},
pages = {851--868},
doi = {10.1016/j.csbj.2025.02.026}
}
EUVIMED